Predictors of adherence to antiretroviral therapy among HIV-infected persons: A prospective study in Southwest Ethiopia

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Amberbir, Alemayehu ^a   Woldemichael, Kifle ^b   Getachew, Sofonias ^c   Girma, Belaineh ^d   Deribe, Kebede ^e  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b JIMMA UNIVERSITY   (Ethiopia)

^c ICAP Ethiopia   (Ethiopia)

^d ADDIS CONTINENTAL INSTITUTE OF PUBLIC HEALTH   (Ethiopia)

^e Fayyaa Integrated Development Association   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE REGIMEN; ETHIOPIA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; SELF REPORT; SOCIAL SUPPORT; STRUCTURED QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; DIET; HOSPITALIZATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; TREATMENT REFUSAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; DEPRESSIVE DISORDER; DIET; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 50149117063     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-265     Document Type: Article

References (43)

1. AIDS epidemic update. UNAIDS/WHO, 2007 "UNAIDS/07.27E/JC1322E".
2. Single Point HIV prevalence estimate. Ministry of Health Ethiopia & Federal HIV/AIDS Prevention and Control Office, Addis Ababa, Ethiopia 2007
3. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. SB Mannheimer J Matts E Telzak M Chesney C Child AW Wu G Friedland, AIDS Care 2005 17 1 10 22 10.1080/09540120412331305098 15832830
4. Antiretroviral treatment adherence and its correlates among people living with HIV/AIDS on highly active antiretroviral therapy in Addis Ababa, Ethiopia. Y Tadios G Davey, EMJ 2006 44 2 237 244
5. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. WHO, 2003
6. Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Addis Ababa Ethiopia. Ministry of Health of Ethiopia, 2005
7. Antiretroviral drugs for all? Panos Global AIDS Program, Obstacles to access to HIV/AIDS: treatment Lessons from Ethiopia, Haiti, India, Nepal and Zambia 2006 http://www.etharc.org/arvinfo/arvsforall.pdf
8. Efficacy of Antiretroviral Therapy Adherence Interventions A Research Synthesis of Trials, 1996 to 2004. K Amico J Rivet Jennifer Harman T Johnson Blair, J Acquir Immune Defic Syndr 2006 41 285 297 10.1097/01.qai.0000197870. 99196.ea 16540929
9. "Supposed to make you better but it doesn't really": HIV-positive youths' perceptions of HIV treatment. C Veinot Tiffany E Flicker Sarah A Skinner Harvey McClelland Alex Saulnierd Paul E Read Stanley Eudice Goldberg, J Adolesc Health 2006 38 3 261 267 10.1016/j.jadohealth.2005.03.008 16488824
10. Treatment adherence to AIDS medications: the Achilles heel of the new therapeutics. JG Rabkin MA Chesney, Psychosocial and Public Health Impacts of New HIV Therapies New York: Kluwer/Plenum, Ostrow D, Kalichman S, 1999 61 68
11. M Carter, Adherence - information series for HIV-positive people London, NAM 3 2005 http://www.aidsmap.com
12. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. RS Hogg K Heath D Bangsberg B Yip N Press MV O'Shaughnessy JS Montaner, AIDS 2002 16 1051 8 10.1097/00002030- 200205030-00012 11953472
13. Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults. B Nachega Jean Hislop Michael W Dowdy David Lo Melanie B Omer Saad Regensberg Leon E Chaisson Richard Maartens Gary, J Acquir Immune Defic Syndr 2006 43 1 1 7 10.1097/01.qai.0000233308.82860.2f 16936557
14. Gender Differences in Factors Associated with Adherence to Antiretroviral Therapy. M Berg Karina A Demas Penelope A Howard Andrea E Schoenbaum Ellie N Gourevitch Marc H Arnsten Julia, J Gen Intern Med 2004 19 1111 1117 15566440 10.1111/j.1525-1497.2004.30445.x
15. DR Bangsberg S Perry ED Charlebois RA Clark M Roberston AR Zolopa A Moss, Non-adherence to highly active antiretroviral therapy predicts progression to AIDS 2001 15 9 1181 1183
16. Adherence to antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Weidle Paul Wamai Nafuna Solberg Peter Liechty Cheryl Sendagala Sam Were Willy Mermin Jonathan Buchacz Kate Behumbiize Prosper L Ransom Ray Bunnell Rebecca, Lancet 2006 368 9547 1556 1557 10.1016/S0140-6736(06)69118-6 17084742
17. J. Adherence practices among people living with HIV. BD Adam e Maticka-Tyndale j Cohen, AIDS care 2005 15 2 263 274 10.1080/0954012031000068407
18. An examination of HIV/AIDS patients who have excellent adherence to HAART. SE Malcolm JJ NG RK Rosen VE Stone, AIDS Care 2003 15 2 251 261 10.1080/0954012031000068399 12856346
19. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. DL Paterson S Swindells J Mohr M Brester EN Vergis C Squier MM Wagener N Singh, Ann Intern Med 2000 133 1 21 30 10877736
20. Better Physician-Patient Relationships Are Associated with Higher Reported Adherence to Antiretroviral Therapy in Patients with HIV Infection. Schneider John H Kaplan Sherrie Greenfield Sheldon Li Wenjun B Wilson Ira, Gen Intern Med 2004 19 1096 1103 10.1111/j.1525-1497.2004.30418.x
21. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. E Carballo C Cadarso-Suarez I Carrera J Fraga Fuente J de la A Ocampo R Ojea A Prieto, Quality of Life research 2004 13 3 587 99 10.1023/B:QURE.0000021315.93360.8b 15130023
22. The relationship of disease severity, health beliefs and medication adherence among patients. X Gao DP Nau SA Rosenbluth V Scott C Woodward, Aids Care 2000 12 4 387 398 10.1080/09540120050123783 11091771
23. Factors affecting adherence to antiretroviral therapy. MA Chesney, Clinl Infec Dis 2000 30 S171 S76 10.1086/313849
24. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Spire Bruno Duran Segolene Souville Marc Leport Catherine Raffi Francois Moattia Jean-Paul, Soc Sci Med 2002 54 1481 1496 10.1016/S0277-9536(01)00125-3 12061483
25. The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence. J Stirratt Michael H Remien Robert Smith Anna Q Copeland Olivia Dolezal Curtis Krieger Daniel, AIDS Behav 2006 10 5 483 93 16721505 10.1007/s10461-006-9106-6
26. Barriers and facilitators to antiretroviral medication among HIV positive patients in Chennai, India: a qualitative study. N Kumarasamy Steven A Safren Sudha R Raminani Robert Pickard Romola James AK Sri Krishnan Suniti Solomon Kenneth H Mayer, AIDS Patient Care and STDs 2005 19 8 526 537 10.1089/apc.2005.19.526
27. Perspectives on Adherence and Simplicity for HIV-Infected Patients on Antiretroviral Therapy: Self-Report of the Relative Importance of Multiple Attributes of Highly Active Antiretroviral Therapy (HAART) Regimens in Predicting Adherence. E Stone Valerie Jordan Jamie Tolson Jerry Miller Robert Pilon Tom, J Acquir Immune Defic Syndr 2004 36 3 808 816 10.1097/00126334- 200407010-00007 15213564
28. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. RG Steele B Anderson B Rindel ML Dreyer K Perrin R Christensen V Tyc PM Flynn, Aids Care 2001 13 5 617 629 10.1080/09540120120063241 11571008
29. The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS. MT Wright, Aids Care 2000 12 6 703 710 10.1080/09540120020014237 11177448
30. Ministry of health of Ethiopia & HIV/AIDS Prevention and Control Office, Monthly HIV Care and ART update, July 8 2007
31. The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort. P Carrieri V Cailleton V Le Moing B Spire P Delllanonica E Bouvet F Raffi V Journot JP Moatti APROCO study group, J Acquir Immune Defiic Syndr 2001 28 232 39
32. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. LN Schonnesson WPM Diamond Ross Michael M Williams G Bratt, AIDS Care 2006 18 3 246 253 16546786
33. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. PT Nieuwkerk MAG Sprangers DM Burger R MW Hotelman's P WH Hugen SA Danner P L Meenhorst H G sprenger H H Kauffmann M Jambroes M A Chesney F de wolf J MA Lange for the ATHENA project, Arch Intern Med 2001 161 1962 68 10.1001/archinte.161.16.1962 11525698
34. Distinguishing between Overlapping Somatic Symptoms of Depression and HIV Disease in People Living with HIV-AIDS. CK Seth R David C Marjorie, J Nerv Ment Dis 2000 188 10 662 670 10.1097/00005053-200010000-00004 11048815
35. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. BE Berger CE Ferrans FR Lashley, Res Nurs Health 2001 24 518 529 10.1002/nur.10011 11746080
36. Statistics notes: Cronbach's alpha. MJ Bland DG Altman, BMJ 1997 314 314 572
37. M Akalu J Haltbakk A Blytad, Barriers to Antiretroviral Treatment Adherence for Patient Living With HIV Infection and AIDS in Arbaminch Hospital, Southern Ethiopia (Abstract), PEPFAR 2006 Ab. 468
38. A Hardon S Davey T Gerritis C Hodgkin H Irunde J Kgatlwane J Kinsman A Nakiyemb R Laing, From access to adherence: the challenges of antiretroviral treatment: studies from Botswana, Tanzania and Uganda 2006
39. Adherence is not a barrier to successful antiretroviral therapy in South Africa. C Orrell DR Bangsberg M Badri R Wood, AIDS 2003 17 1369 75 10.1097/00002030-200306130-00011 12799558
40. Determinants of compliance with antiretroviral therapy in patients with human immunodefiency virus: prospective assessment with implications for enhancing compliance. C Singh C Squier M Sivek M Wagener Hong Nguyen VL Yu, AIDS Care 1996 8 3 261 9 10.1080/09540129650125696 8827119
41. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. G Godin J Cote H Naccache LD Lambert S Trottier, AIDS Care 2005 17 4 493 504 16036235
42. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparisons of self-report and electronic monitoring. JH Arnsten PA Demas H Farzadegan RW Grant MN Gaurevitch CJ Changa D Buono H Eckholdt AA Howard EE Schoenbaum, Clin Infect Dis 2001 33 8 1417 1423 10.1086/323201 11550118
43. Is the influence of social desirability on patients' self-reported adherence overrated? G Wagner LG Miller, J Acquir Immune Defic Syndr 2004 35 203 204 10.1097/00126334-200402010-00016 14722455